|3Feb 4, 6:25 PM ET

Brookside Capital Trading Fund, L.P. 3

3 · Dicerna Pharmaceuticals Inc · Filed Feb 4, 2014

Insider Transaction Report

Form 3
Period: 2014-02-04
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,337,000
Footnotes (1)
  • [F1]Brookside Capital Management, LLC ("BCM") is the sole general partner of Brookside Capital Investors, L.P. ("BCI") and Brookside Capital Investors II, L.P. ("BCI II"). BCI is the sole general partner of Brookside Capital Partners Fund, L.P. ("BCPF") and BCI II is the sole general partner of Brookside Capital Trading Fund, L.P ("BCTF"). BCM, BCI and BCI II each may be deemed to share voting dispositive powers with respect to the shares held by each BCPF and BCTF. Each of BCM, BCI and BCI II disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.

Documents

1 file
  • 3
    rrd401335.xmlPrimary

    FORM 3